October 28, 2016 2:54 AM ET


Company Overview of Johnson & Johnson Consumer Inc.

Company Overview

Johnson & Johnson Consumer Inc. produces and markets over-the-counter (OTC) products to families, children, healthcare professionals, and other consumers in the United States and internationally. The company offers TYLENOL product line that consists of products across various pain categories, including arthritis pain, pain with accompanying sleeplessness, and symptoms of cold and flu in the adult and pediatric categories’; BENADRYL, ZYRTEC, and ZYRTEC-D allergy medicines; IMODIUM anti-diarrheal products; and SUDAFED PE nasal decongestants. It provides OTC products for relief of pain and fever, cold and flu, sinus and allergy, digestive health, sleeplessness, hair/scalp care, and children car...

7050 Camp Hill Road

Fort Washington, PA 19034-2210

United States





Key Executives for Johnson & Johnson Consumer Inc.

Johnson & Johnson Consumer Inc. does not have any Key Executives recorded.

Johnson & Johnson Consumer Inc. Key Developments

Xycrobe Therapeutics Signs Research Agreement with Johnson & Johnson

Xycrobe Therapeutics has signed a research agreement with United States-based Johnson & Johnson Consumer. The partnership is aimed at concentrating on further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases. It is intended to provide both firms with information on how the Xycrobe technology is likely to be best applied to future therapeutic and commercial applications.

McNeil-PPC Inc. Agrees to Pay $25 million Under Criminal Resolution

McNeil-PPC Inc. pled guilty to a single count of an information alleging the firm with supplying for introduction into interstate commerce contaminated infants' and children's liquid over-the-counter (OTC) drugs. Under the criminal resolution, McNeil will pay a criminal penalty of $20 million and forfeit $5 million. A lawsuit was filed against the company in federal court in Philadelphia alleging that it had delivered for introduction into interstate commerce infants' and children's liquid OTC medicines that were adulterated. Federal officials said the infants' and children's liquid drugs were contaminated as they were not produced, processed, packaged or held in line with current Good Manufacturing Practices (cGMP), in breach of the federal Food, Drug and Cosmetic Act (FDCA). In addition to the company's guilty plea, McNeil continues to be subject to a permanent injunction passed by the U.S. District Court in 2011, asking the company, among other things, to take remedial steps before reopening its production plant in Fort Washington, Pennsylvania.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

July 25, 2016
Johnson & Johnson Consumer Inc., Rembrandt Brand
April 26, 2016
NeoStrata Company, Inc.
March 2, 2016
The Procter & Gamble Company, Hipoglós Brand

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Johnson & Johnson Consumer Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.